Drug profile · INN
fluorometholone acetate
FLAREX
fluorometholone acetate (FLAREX) is a glucocorticoid receptor agonist. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — fluorometholone acetate
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
fluorometholone acetate (FLAREX) is a glucocorticoid receptor agonist. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Glucocorticoid receptor agonist
Primary target: Glucocorticoid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is fluorometholone acetate?
fluorometholone acetate (FLAREX) is a glucocorticoid receptor agonist. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for fluorometholone acetate?
FLAREX is a marketed brand name for fluorometholone acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of fluorometholone acetate?
fluorometholone acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.